RHYTHM PHARMACEUTICALS INC (RYTM) Stock Cash Flow
NASDAQ:RYTM - Nasdaq - US76243J1051 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -168.73M | -260.60M | -184.68M | -181.12M | -69.61M | |||
| Depreciation Amortization | 1.54M | 1.56M | 1.76M | 1.67M | 1.16M | |||
| Change In Working Capital | 4.85M | 10.57M | 4.81M | -19.72M | 1.90M | |||
| Other non cash items | 48.85M | 134.59M | 41.96M | 25.74M | -79.45M | |||
| OPERATING CASH FLOW | -113.49M | -113.88M | -136.16M | -173.43M | -146.00M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | -47.00K | -280.00K | -430.00K | |||
| Other Investing Activity | -53.41M | -48.17M | -5.62M | 28.31M | -61.73M | |||
| INVESTING CASH FLOW | -53.41M | -48.17M | -5.67M | 28.03M | -62.16M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -14.73M | -12.90M | 16.97M | 72.34M | N/A | |||
| Stock Issued/Repurchased | 225.33M | 195.24M | 57.40M | 141.49M | 166.48M | |||
| Other Financing Activity | N/A | 8.90M | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 219.50M | 191.24M | 74.37M | 213.83M | 166.48M | |||
| Exchange Rate Effect | 71.00K | 2.00K | -142.00K | N/A | N/A | |||
| CHANGE IN CASH | 52.67M | 29.19M | -67.60M | 68.43M | -41.68M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -113.49M | -113.88M | -136.16M | -173.43M | -146.00M | |||
| Capital Expenditure | N/A | N/A | -47.00K | -280.00K | -430.00K | |||
| FREE CASH FLOW | -113.49M | -113.88M | -136.20M | -173.71M | -146.43M | |||
All data in USD